Capecitabine With Digoxin for Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Digoxin
Sponsor: Western Regional Medical Center